Current Psychosomatic Practice

Psychotherapy and Psychosomatics

Volumn 86, Issue 1, 2017, Pages 13-30

  Fava, Giovanni A ^a,d   Cosci, Fiammetta ^b   Sonino, Nicoletta ^c,d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

Allostatic load; Anxiety; Clinimetrics; Depression; Diagnostic criteria for psychosomatic research; Illness behavior; Patient reported outcomes; Psychosomatic medicine; Psychotherapy; Stress

Indexed keywords

ALEXITHYMIA; ATTITUDE TO HEALTH; CLINICAL PRACTICE; DEMORALIZATION; HEALTH BEHAVIOR; HEALTH CARE NEED; HUMAN; ILLNESS BEHAVIOR; IRRITABILITY; NONHUMAN; PATIENT-REPORTED OUTCOME; PERSONALITY; PRIORITY JOURNAL; PSYCHOLOGICAL WELL-BEING; PSYCHOPHARMACOLOGY; PSYCHOSOMATICS; QUALITY OF LIFE; RELIGION; REVIEW; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; TYPE A BEHAVIOR; PERSONALIZED MEDICINE; PSYCHOLOGY; PSYCHOPHYSIOLOGIC DISORDERS;

HUMANS; PRECISION MEDICINE; PSYCHOLOGY; PSYCHOPHYSIOLOGIC DISORDERS; PSYCHOSOMATIC MEDICINE;

EID: 85000948400     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000448856     Document Type: Review

References (229)

1. Lipowski ZJ: Psychosomatic medicine: past and present. Can J Psychiatry 1986; 31: 2-21.
2. Fava GA, Sonino N: Psychosomatic medicine: emerging trends and perspectives. Psychother Psychosom 2000; 69: 184-197.
3. Fava GA, Sonino N: The clinical domains of psychosomatic medicine. J Clin Psychiatry 2005; 66: 849-858.
4. Fava GA, Sonino N: Psychosomatic medicine. Int J Clin Practice 2010; 64: 1155-1161.
5. Wise TN: Psychosomatics: past, present and future. Psychother Psychosom 2014; 83: 65-69.
6. Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T, Wise TN: Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995; 63: 1-8.
7. Porcelli P, Sonino N (eds): Psychological Factors Affecting Medical Conditions. Basel, Karger, 2007.
8. Porcelli P, Guidi J: The clinical utility of the Diagnostic Criteria for Psychosomatic Research: a review of studies. Psychother Psychosom 2015; 84: 265-272.
9. Altamura M, Porcelli P, Balzotti A, Massaro CR, Bellomo A: Influence of DCPR syndromes in the psychosocial functioning of patients with major depressive and bipolar disorders. Psychother Psychosom 2015; 84: 387-388.
10. Miller NE: Behavioral medicine: symbiosis between laboratory and clinic. Annu Rev Psychol 1983; 34: 1-31.
11. Andrasik F, Goodie JL, Peterson AL: Biopsychosocial Assessment in Clinical Health Psychology. New York, Guilford Press, 2015.
12. Gordon JS: Manifesto for a New Medicine. Reading, Addison-Wesley, 1996.
13. Rakel D: Integrative Medicine, ed. 2. Philadelphia, Saunders, 2007.
14. Thabrew H, de Sylva S, Romans SE: Evaluating childhood adversity. Adv Psychosom Med 2012; 32: 35-57.
15. McEwen BS: Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007; 87: 873-904.
16. Danese A, McEwen BS: Adverse childhood experiences, allostasis, allostatic load and agerelated disease. Physiol Behav 2012; 106: 29-39.
17. Novack DH, Cameron O, Epel E, Ader R, Waldstein SR, Levenstein S, Antoni MH, Wainer AR: Psychosomatic medicine: the scientific foundation of the biopsychosocial model. Acad Psychiatry 2007; 31: 388-401.
18. Theorell T: Evaluating life events and chronic stressors in relation to health. Adv Psychosom Med 2012; 32: 58-71.
19. Fink G (ed): Stress Concept and Cognition, Emotion, and Behaviour. San Diego, Elsevier, 2016.
20. Nemeroff CB: Paradise lost: the neurobiological and clinical consequences of child abuse and neglect. Neuron 2016; 89: 892-909.
21. Grippo AJ, Scotti MA: Stress and neuroinflammation. Mod Trends Pharmacopsychiatry 2013; 28: 20-32.
22. Nemeroff CB, Goldschmidt-Clermont PJ: Heartache and heartbreak-the link between depression and cardiovascular disease. Nat Rev Cardiol 2012; 9: 526-539.
23. Schöttker B, Saum KU, Jansen EH, Holleczek B, Brenner H: Associations of metabolic, inflammatory and oxidative stress markers with total morbidity and multi-morbidity in a large cohort of older German adults. Age Ageing 2016; 45: 127-135.
24. Fava GA, Guidi J, Semprini F, Tomba E, Sonino N: Clinical assessment of allostatic load and clinimetric criteria. Psychother Psychosom 2010; 79: 280-284.
25. Offidani E, Ruini C: Psychobiological correlates of allostatic overload in a healthy population. Brain Behav Immun 2012; 26: 284-291.
26. Offidani E, Rafanelli C, Gostoli S, Marchetti G, Roncuzzi R: Allostatic overload in patients with atrial fibrillation. Int J Cardiol 2013; 165: 375-376.
27. Tomba E, Offidani E: A clinimetric evaluation of allostatic overload in the general population. Psychother Psychosom 2012; 81: 378-379.
28. Guidi J, Offidani E, Rafanelli C, Roncuzzi R, Sonino N, Fava GA: The assessment of allostatic overload in patients with congestive heart failure by clinimetric criteria. Stress Health 2016; 32: 63-69.
29. McEwen BS, Bowles NP, Gray JD, Hill MN, Hunter RG, Karatsoreos IN, Nasca C: Mechanisms of stress in the brain. Nat Neurosci 2015; 18: 1353-1363.
30. McEwen BS, Gianaros PJ: Stress-and allostasis-induced brain plasticity. Annu Rev Med 2011; 62: 431-445.
31. Mokdad AH, Marks JS, Stroup DF, Gerberding JL: Actual causes of death in the United States, 2000. JAMA 2004; 291: 1238-1245.
32. Agirbasli M, Tanrikulu AM, Berenson GS: Metabolic syndrome: bridging the gap from childhood to adulthood. Cardiovasc Ther 2016; 34: 30-36.
33. Emmen MJ, Peters E, Elving LD, Bredie SJH, Wollersheim H, Bleijenberg G, Schippers GM: A brief behavioral feedback intervention in hospital outpatients with a high cardiovascular risk. Patient Educ Couns 2006; 60: 32-40.
34. Steptoe A, Wardle J: Cognitive predictors of health behavior in contrasting regions of Europe. Br J Clin Psychol 1992; 31: 485-502.
35. Gianaros PJ, Manuck SB: Neurobiological pathways linking socioeconomic position and health. Psychosom Med 2011; 72: 450-461.
36. Roy R: Social Support, Health and Illness. A Complicated Relationship. Toronto, University of Toronto Press, 2011.
37. Pressman SD, Cohen S: Does positive affect influence health? Psychol Bull 2005; 131: 925-971.
38. Ryff CD: Psychological well-being revisited: advances in the science and practice of eudaimonia. Psychother Psychosom 2014; 83: 10-28.
39. Fava GA, Bech P: The concept of euthymia. Psychother Psychosom 2016; 85: 1-5.
40. Cole SW: Human social genomics. PLoS Genet 2014; 10:e1004601.
41. Currier MB, Nemeroff CB: Depression as a risk factor for cancer. Annu Rev Med 2014; 65: 203-221.
42. Frederickson BL, Grewen KM, Algoes SB, Firestine AM, Arevalo JM, Ma J, Cole SW: Psychological well-being and the human conserved transcriptional response to adversity. PLoS One 2015; 10:e0121839.
43. Chida Y, Steptoe A, Powell LH: Religiosity/spirituality and mortality. Psychother Psychosom 2009; 78: 81-90.
44. Morandi A, Narayanan Nambi AN (eds): An Integrated View of Health and Well-being. Dordrecht, Springer, 2013.
45. Cosci F: Assessment of personality in psychosomatic medicine: current concepts. Adv Psychosom Med 2012; 32: 133-159.
46. Friedman M, Rosenman RH: Type A Behavior and Your Heart. New York, Knopf, 1974.
47. Sirri L, Fava GA, Guidi J, Porcelli P, Rafanelli C, Bellomo A, Grandi S, Grassi L, Pasquini P, Picardi A, Quartesan R, Rigatelli M, Sonino N: Type A behavior: a reappraisal of its characteristics in cardiovascular disease. Int J Clin Pract 2012; 66: 854-861.
48. De Vries AM, Forni V, Voellinger R, Stiefel F: Alexithymia in cancer patients: review of the literature. Psychother Psychosom 2012; 81: 79-86.
49. Lumley MA, Neely LC, Burger AJ: The assessment of alexithymia in medical settings: implications for understanding and treating health problems. J Pers Assess 2007; 89: 230-246.
50. Porcelli P, Bagby RM, Taylor GJ, De Carne M, Leandro G, Todarello O: Alexithymia as predictor of treatment outcome in patients with functional gastrointestinal disorders. Psychosom Med 2003; 65: 911-918.
51. Honkalampi K, Lehto SM, Koivumaa-Honkanen H, Hintikka J, Niskanen L, Valkonen-Korhonen M, Viinamäki H: Alexithymia and tissue inflammation. Psychother Psychosom 2011; 80: 359-364.
52. Cloninger CR: A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry 1987; 44: 573-588.
53. De Gucht V, Heiser W: Alexithymia and somatisation: quantitative review of the literature. J Psychosom Res 2003; 54: 425-434.
54. Fava M, Littman A, Halperin P: Neuroendocrine correlates of the type A behavior pattern. Int J Psychiatry Med 1987; 17: 289-307.
55. Engel GL: The need for a new medical model: a challenge for biomedicine. Science 1977; 196: 129-136.
56. Levenstein S: Stress and peptic ulcer: life beyond helicobacter. BMJ 1999; 316: 538-541.
57. Waeldin S, Vogt D, Linden M, Hellhammer DH: Frequency of perceived post-stress symptoms in inpatients, outpatients and healthy controls. Psychother Psychosom 2016; 85: 36-44.
58. Katon WJ, Walker EA: Medically unexplained symptoms in primary care. J Clin Psychiatry 1998; 59: 15-21.
59. Hahn SR, Thompson KS, Wills TA, Stern V, Budner NS: The difficult doctor-patient relationship. J Clin Epidemiol 1994; 47: 647-657.
60. Sonino N, Guidi J, Fava GA: Psychological aspects of endocrine disease. J R Coll Physicians Edinb 2015; 45: 55-59.
61. Fava GA, Sonino N, Wise TN (eds): The Psychosomatic Assessment. Basel, Karger, 2012.
62. Keifenheim KE, Teufel M, Ip J, Speiser N, Leehr EJ, Zipfel S, Herrmann-Werner A: Teaching history taking to medical students. BMC Med Edu 2015; 15: 159.
63. Engel GL: A unified concept of health and disease. Perspect Biol Med 1960; 3: 459-485.
64. Hinkle LH: Human ecology and psychosomatic medicine. Psychosom Med 1967; 29: 391-395.
65. Levin BW, Browner CH: The social production of health. Soc Sci Med 2005; 61: 745-750
66. Tinetti ME, Fried T: The end of the disease era. Am J Med 2004; 116: 179-185.
67. Feinstein AR: The Jones criteria and the challenge of clinimetrics. Circulation 1982; 66: 1-5.
68. Bech P: Clinimetric dilemmas in outcome scales for mental disorders. Psychother Psychosom 2016;85:323-326.
69. Fava GA, Tomba E, Sonino N: Clinimetrics: the science of clinical measurements. Int J Clin Pract 2012; 66: 11-15.
70. Tomba E, Bech P: Clinimetrics and clinical psychometrics. Psychother Psychosom 2012; 81: 333-340.
71. Cosci CF, Svicher A, Bech P: The Family Assessment Device. A clinimetric analysis. Psychother Psychosom 2016; 85: 241-243.
72. Piolanti A, Offidani E, Guidi J, Gostoli S, Fava GA, Sonino N: Use of the PsychoSocial Index (PSI), a sensitive tool in research and practice. Psychother Psychosom 2016;85:337-345.
73. Grassi L, Berardi MA, Ruffilli F, Meggiolaro E, Andritsch E, Sirgo A, Caruso R, Juan Linares E, Bellé M, Massarenti S, Nanni MG; IOR-IRST Psycho-Oncology and UniFE Psychiatry Co-Authors: Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study. Psychother Psychosom 2015; 84: 339-347.
74. Evers AW, Gieler U, Hasenbring MI, van Middendorp H: Incorporating biopsychosocial characteristics into personalized healthcare: a clinical approach. Psychother Psychosom 2014; 83: 148-157.
75. Derogatis LR, Lipman RS, Covi L: SCL-90: an outpatient psychiatric rating scale-preliminary report. Psychopharmacol Bull 1973; 9: 13-28.
76. Snaith RP, Zigmond AS: The hospital anxiety and depression scale. Br Med J (Clin Res Ed) 1986; 292: 344.
77. Kellner R: A symptom questionnaire. J Clin Psychiatry 1987; 48: 268-274.
78. Bech P: Clinical Psychometrics. Oxford, Wily-Blackwell, 2012.
79. Bech P: Measurement of psychological distress and well-being. Psychother Psychosom 1990; 54: 77-89.
80. Rodriguez-Urrutia A, Eiroa-Orosa FJ, Accarino A, Malagelada C, Azpiroz F: Incongruence between clinicians' assessments and selfreport functioning is related to psychopathology among patients diagnosed with gastrointestinal disorders. Psychother Psychosom 2016; 85: 244-245.
81. Topp CW, Østergaard SD, Søndergaard S, Bech P: The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom 2015; 84: 167-176.
82. Bottomley A, Jones D, Claassens L: Patientreported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicine Agency. Eur J Cancer 2009; 45: 347-353.
83. Clancy C, Collins FS: Patient-Center Outcomes Research Institute: the intersection of science and health care. Sci Transl Med 2010; 3: 37.
84. Concato J, Feinstein AR: Asking patients what they like: overlooked attributes of patient satisfaction with primary care. Am J Med 1997; 102: 399-406.
85. Mechanic D, Volkart EH: Illness behavior and medical diagnoses. J Health Hum Behav 1960; 1: 86-94.
86. Mechanic D: Sociological dimensions of illness behavior. Soc Sci Med 1995; 41: 1207-1216.
87. Sirri L, Fava GA, Sonino: The unifying concept of illness behavior. Psychother Psychosom 2013; 82: 74-81.
88. Cosci F, Fava GA: The clinical inadequacy of the DSM-5 classification of somatic symptom and related disorders: an alternative trans-diagnostic model. CNS Spectr 2016;21:310-317.
89. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 5. Washington, American Psychiatric Association, 2013.
90. Fava GA, Grandi S: Differential diagnosis of hypochondriacal fears and beliefs. Psychother Psychosom 1991; 55: 114-119.
91. Noyes R, Carney CP, Langbehn DR: Specific phobia of illness: search for a new subtype. J Anxiety Disord 2004; 18: 531-545.
92. Porcelli P, Bellomo A, Quartesan R, Altamura M, Iuso S, Ciannameo I, Piselli M, Elisei S: Psychosocial functioning in consultation-liaison psychiatry patients: influence of psychosomatic syndromes, psychopathology and somatization. Psychother Psychosom 2009; 78: 352-358.
93. Galeazzi GM, Ferrari S, Mackinnon A, Rigatelli M: Interrater reliability, prevalence, and relation to ICD-10 diagnoses of the Diagnostic Criteria for Psychosomatic Research in consultation-liaison psychiatry patients. Psychosomatics 2004; 45: 386-393.
94. Kellner R: Psychosomatic syndromes, somatization and somatoform disorders. Psychother Psychosom 1994; 61: 4-24.
95. Mayer EA, Tillisch K: The brain-gut axis in abdominal pain syndromes. Annu Rev Med 2011; 62: 381-396.
96. Mayer EA, labus JS, Tillisch K, Cole SW, Baldi P: Toward a systems view of IBS. Nat Rev Gastroenterol Hepatol 2015; 12: 592-605.
97. Ly HG, Ceccarini J, Weltens N, Bormans G, Van Laere K, Tack J, Van Oudenhove L: Increased cerebral cannabinoid-1 receptor availability is a stable feature of functional dyspepsia: a [18 F]MK-9470 PET study. Psychother Psychosom 2015; 84: 149-158.
98. Engel GL: Conversion symptoms; in Mac-Bryde CM, Blacklow RS (eds): Signs and Symptoms, Applied Pathological Physiology and Clinical Interpretation. Philadelphia, Lippincott, 1970, pp 650-668.
99. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
100. Porcelli P, Fava GA, Rafanelli C, Bellomo A, Grandi S, Grassi L, Pasquini P, Picardi A, Quartesan R, Rigatelli M, Sonino N: Anniversary reactions in medical patients. J Nerv Ment Dis 2012; 200: 603-606.
101. Grassi L, Sabato S, Rossi E, Biancosino B, Marmai L: Use of the diagnostic criteria for psychosomatic research in oncology. Psychother Psychosom 2005; 74: 100-107.
102. Grandi S, Sirri L, Tossani E, Fava GA: Psychological characterization of demoralization in the setting of heart transplantation. J Clin Psychiatry 2011; 72: 648-654.
103. Pilowsky I: Abnormal Illness Behaviour. Chichester, Wiley, 1997.
104. Frank JD: Persuasion and Healing. Baltimore, Johns Hopkins University Press, 1961.
105. Schmale AH, Engel GL: The giving up-given up complex illustrated on film. Arch Gen Psychiatry 1967; 17: 133-145.
106. Tecuta L, Tomba E, Grandi S, Fava GA: Demoralization: a systematic review on its clinical characterization. Psychol Med 2015; 45: 673-691.
107. Sweeney DR, Tinling DC, Schmale AH: Differentiation of the 'giving-up' affects-helplessness and hopelessness. Arch Gen Psychiatry 1970; 23: 378-382.
108. Benedetti F: The Patient's Brain. The Neuroscience behind the Doctor-Patient Relationship. Oxford, Oxford University Press, 2011.
109. Snaith RP, Taylor CM: Irritability. Br J Psychiatry 1985; 147: 127-136.
110. Fava GA: Irritable mood and physical illness. Stress Med 1987; 3: 293-299.
111. Miller TQ, Smith TW, Turner CW, Guijarro ML, Hallet AJ: A meta-analytic review of research on hostility and physical health. Psychol Bull 1996; 119: 322-348.
112. Chida Y, Steptoe A: The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence. J Am Coll Cardiology 2009; 53: 936-946.
113. Lemogne C, Nabi H, Zins M, Cordier S, Ducimetière P, Goldberg M, Consoli SM: Hostility may explain the association between depressive mood and mortality: evidence from the French GAZEL cohort study. Psychother Psychosom 2010; 79: 164-171.
114. Klabbers G, Bosma H, van den Akker M, Kempen GI, van Eijk JT: Cognitive hostility predicts all-cause mortality irrespective of behavioural risk at late middle and older age. Eur J Public Health 2013; 23: 701-705.
115. Sonino N, Navarrini C, Ruini C, Ottolini F, Paoletta A, Fallo F, Boscaro M, Fava GA: Persistent psychological distress in patients treated for endocrine disease. Psychother Psychosom 2004; 73: 78-83.
116. Sartorius N, Holt RIG, Maj M (eds): Comorbidity of Mental and Physical Disorders. Basel, Karger, 2015.
117. Cosci F, Fava GA, Sonino N: Mood and anxiety disorders as early manifestations of medical illness. Psychother Psychosom 2015; 84: 22-29.
118. Fava GA, Sonino N: Depression associated with medical illness. CNS Drugs 1996; 5: 175-189.
119. Mitchell Aj, Vaze A, Rao S: Clinical diagnosis of depression in primary care: a metaanalysis. Lancet 2009; 374: 609-619.
120. Rafanelli C, Sirri L, Grandi S, Fava GA: Is depression the wrong treatment target for improving outcome in coronary artery disease? Psychother Psychosom 2013; 82: 285-291.
121. Sonino N, Fava GA, Raffi AR, Boscaro M, Fallo F: Clinical correlates of major depression in Cushing's disease. Psychopathology 1998; 31: 302-306.
122. Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M: Risk factors and long-term outcome in pituitary-dependent Cushing's disease. J Clin Endocrinol Metab 1996; 81: 2647-2652.
123. Katon WJ: Clinical and health services relationships between major depression, depressive symptoms and general medical illness. Biol Psychiatry 2003; 54: 216-226.
124. Di Matteo MR, Lepper HS, Croghan TW: Depression is a risk factor for noncompliance with medical treatment. Arch Intern Med 2000; 160: 2101-2107.
125. Lipowski ZJ: Physical illness and psychopathology. Int J Psychiatry Med 1974; 5: 483-497.
126. Schulz R, Drayer RA, Rollman BL: Depression as a risk factor for non-suicide mortality in the elderly. Biol Psychiatry 2002; 52: 205-225.
127. Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJG, Goodwin RD, Kubzansky L, Lydiard RB, Massic MJ, Katon WJ, Laden SK, Stein MB: Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008; 30: 208-225.
128. Fava GA, Porcelli P, Rafanelli C, Mangelli L, Grandi S: The spectrum of anxiety disorders in the medically ill. J Clin Psychiatry 2010; 71: 910-914.
129. Niles AN, Dour HJ, Stanton AL, Roy-Byrne PP, Stein MB, Sullivan G, Sherbourne CD, Rose RD, Craske MG: Anxiety and depressive symptoms and medical illness among adults with anxiety disorders. J Psychosom Res 2015; 78: 109-115.
130. Hanel G, Henningsen P, Herzog W, Sauer N, Schaefert R, Szecsenyi J, Löwe B: Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study. J Psychosom Res 2009; 67: 189-197.
131. Fava GA, Guidi J, Porcelli P, Rafanelli C, Bellomo A, Grandi S, Grassi L, Mangelli L, Pasquini P, Picardi A, Quartesan R, Rigatelli M, Sonino N: A cluster analysis-derived classification of psychological distress and illness behavior in the medically ill. Psychol Med 2012; 42: 401-407.
132. Semprini F, Fava GA, Sonino N: The spectrum of adjustment disorders: too broad to be clinically helpful. CNS Spectr 2010; 15: 382-388.
133. Emmelkamp PM, Bouman TK, Scholing A: Anxiety Disorders. Chichester, Wiley, 1993.
134. Kroenke K, Mangelsdorff D: Common symptoms in ambulatory care. Am J Med 1989; 86: 262-268.
135. Konnopka A, Schaefert R, Heinrich S, Kaufman C, Luppa M, Herzog, Konig HH: Economics of medical unexplained symptoms. Psychother Psychosom 2012; 81: 265-275.
136. Croicu C, Chwastiak L, Katon W: Approach to the patient with multiple somatic symptoms. Med Clin North Am 2014; 98: 1079-1095.
137. Sonino N, Fava GA: Improving the concept of recovery in endocrine disease by consideration of psychosocial issues. J Clin Endocrinol Metab 2012; 97: 2614-2616.
138. Kornfeld DS: Consultation-liaison psychiatry: contributions to medical practice. Am J Psychiatry 2012; 159: 1964-1972.
139. Fava GA, Cosci F, Offidani E, Guidi J: Behavioral toxicity revisited: iatrogenic comorbidity in psychiatric evaluation and treatment. J Clin Psychopharmacol, in press.
140. Djoussé L, Driver JA, Graziano JM: Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA 2009; 302: 394-400.
141. Forman JP, Stampfer MJ, Curhan GC: Diet and lifestyle risk factors associated with incident hypertension in women. JAMA 2009; 302: 401-411.
142. Tomba E: Assessment of lifestyle in relation to health. Adv Psychosom Med 2012; 32: 72-96.
143. Stone NJ: Focus on lifestyle change and the metabolic syndrome. Endocrinol Metab Clin North Am 2004; 33: 493-508.
144. Shonkoff JP, Boyce WT, McEwen BS: Neuroscience, molecular biology and the childhood roots of health disparities. JAMA 2009; 301: 2252-2259.
145. Abramson J: Overdosed America. New York, HarperCollins, 2004.
146. Leventhal H, Weinman J, Leventhal EA, Phillips LA: Health psychology: the search for pathways between behavior and health. Annu Rev Psychol 2008; 59: 477-505.
147. Smith TW, Williams PG: Behavioral medicine and clinical health psychology; in Lambert MJ (ed): Bergin and Garfield's Handbook of Psychotherapy and Behavior Change, ed 6. Hoboken, Wiley, 2013, pp 690-734.
148. Gerger H, Hlavica M, Gaab J, Munder T, Barth J: Does it matter who provides psychological interventions for medically unexplained symptoms? A meta-analysis. Psychother Psychosom 2015; 84: 217-226.
149. Rickels K (ed): Non-specific factors in drug therapy. Springfield, Charles C. Thomas, 1968.
150. Gliedman CH, Nash EH, Huber SD, Stone AR, Frank JD: Reduction of symptoms by pharmacologically inert substances and by short-term psychotherapy. AMA Arch Neurol Psychiatry 1958; 79: 345-351.
151. Zilcha-Mano S, Roose SP, Barber JP, Rutherford BR: Therapeutic alliance in antidepressant treatment: cause or effect of symptomatic levels? Psychother Psychosom 2015; 84: 177-182.
152. Walach H: Placebo effects in complementary and alternative medicine: the self-healing response; In Colloca L, Flaten MA, Meissner K (eds): Placebo and Pain. London, Academic Press, 2013, pp 189-202.
153. Schedlowski M, Enck P, Rief, Bingel U: Neuro-bio-behavioral mechanisms of placebo and nocebo responses: implications for clinical trials and clinical practice. Pharmacol Rev 2015; 67: 697-730.
154. Egbert LD, Battit GE, Welch CE, Bartlett MK: Reduction of postoperative pain by encouragement and instruction of patients. N Engl J Med 1964; 270: 825-827.
155. Uhlenhuth EN, Rickels K, Fisher S, Park LC, Lipman RS, Mock J: Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy. Psychopharmacologia 1966; 9: 392-418.
156. Enck P, Bingel U, Schedlowski M, Rief W: The placebo response in medicine: minimize, maximize or personalize? Nature Rev Drug Discov 2013; 12: 191-204.
157. Kaupp JW, Rapaport-Hubschman N, Spiegel D: Psychosocial treatments; in Levenson JL (ed): Textbook of Psychosomatic Medicine. Washington, American Psychiatric Press, 2005, pp 923-956.
158. Abbass A, Kisely S, Kroenke K: Short-term psychodynamic psychotherapy for somatic disorders. Psychother Psychosom 2009; 78: 265-274.
159. Hartmannn M, Bazner E, Wild B, Eisler I, Herzog W: Effects of interventions involving the family in the treatment of adult patients with chronic physical disease. Psychother Psychosom 2010; 79: 136-148.
160. Cosci F, Fava GA: Psychotherapeutic Interventions; in Carvalho AF, Manning JS, Mc-Intyre RS (eds): Mental Disorders in Primary Care. A Guide to their Evaluation and Treatment. London, Oxford University Press, in press.
161. Rozanski A, Blumenthal JA, Kaplan J: Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999; 99: 2192-2217.
162. Janssen V, Gucht VD, Dusseldorp E, Maes S: Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials. Eur J Prev Cardiol 2013; 20: 620-640.
163. Dindo L, Marchman J, Gindes H, Fiedorowicz JG: A brief behavioral intervention targeting mental health risk factors for vascular disease. Psychother Psychosom 2015; 84: 183-185.
164. Gulliksson M, Burell G, Vessby B, Lundin L, Toss H, Svärdsudd K: Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM). Arch Intern Med 2011; 171: 134-140.
165. Rankin P, Morton DP, Diehl H, Gobble J, Morey P, Chang E: Effectiveness of a volunteer-delivered lifestyle modification program for reducing cardiovascular disease risk factors. Am J Cardiol 2012; 109: 82-86.
166. Laird KT, Tanner-Smith EE, Russell AC, Hollon SD, Walker LS: Short-term and longterm efficacy of psychological therapies for irritable bowel syndrome. Clin Gastroenterol Hepatol 2016; 14: 937-947.e4.
167. Farver-Vestergaard I, Jacobsen D, Zachariae R: Efficacy of psychosocial interventions on psychological and physical health outcomes in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Psychother Psychosom 2015; 84: 37-50.
168. Thibault RT, Lishfitz M, Birbaumer N, Raz A: Neurofeedback, self-regulation and brain imaging. Psychother Psychosom 2015; 84: 193-207.
169. Turk DC, Swanson KS, Tunks ER: Psychological approaches in the treatment of chronic pain patients. Can J Psychiatry 2008; 53: 213-223.
170. Dale R, Stacey B: Multimodal treatment of chronic pain. Med Clin North Am 2016; 100: 55-64.
171. Diabetes Prevention Program Research Group: Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up. Lancet Diabetes Endocrinol 2015; 3: 866-879.
172. Tovote KA, Schroevers MJ, Snippe E, Sanderman R, Links TP, Emmelkamp PM, Fleer J: Long-term effects of individual mindfulness-based cognitive therapy and cognitive behavior therapy for depressive symptoms in patients with diabetes: a randomized trial. Psychother Psychosom 2015; 84: 186-187.
173. Scott-Sheldon LA, Kalichman SC, Carey MP, Fielder RI: Stress management interventions for HIV+ adults. Health Psychol 2008; 27: 129-139.
174. Crepaz N, Tungol-Ashmon MV, Higa DH, Vosburgh VV, Mullins MM, Barham T, Adegbite A, DeLuca JB, Sipe TA, White CM, Baack BN, Lyles CM: A systematic review of interventions for reducing HIV risk behaviors among people living with HIV in the United States, 1988-2012. AIDS 2014; 28: 633-656.
175. Andersen BL, Yang HC, Farrar WB, Golden-Krentz DM, Emery CF, Thornton LM, Young DC, Carson WE: Psychologic intervention improves survival for breast cancer patients. Cancer 2008; 113: 3450-3458.
176. Minton O, Jo F, Jane M: The role of behavioural modification and exercise in the management of cancer-related fatigues to reduce its impact during and after cancer treatment. Acta Oncol 2015; 54: 581-586.
177. Julião M, Nunes B, Barbosa A: Dignity therapy and its effect on the survival of terminally ill Portuguese patients. Psychother Psychosom 2015; 84: 57-58.
178. Hou RJ, Wong SYS, Yip BHB, Hung ATF, Lo HHM, Chan PHS, Lo CSL, Kwok TCY, Tang WK, Mak WWS, Mercer SW, Ma SH: The effects of mindfulness-based stress reduction program on the mental health of family caregivers. Psychother Psychosom 2014; 83: 45-53.
179. Fava GA: Well-Being Therapy. Treatment Manual and Clinical Applications. Basel, Karger, 2016.
180. Fava GA: Well-Being Therapy: current indications and emerging perspectives. Psychother Psychosom 2016; 85: 136-145.
181. Hasler G: Well-being. An important concept for psychotherapy and psychiatric neuroscience. Psychother Psychosom 2016; 85: 255-261.
182. Sirri L, Ricci Garotti MG, Grandi S, Tossani E: Adolescents' hypochondriacal fears and beliefs. J Psychosom Res 2015; 79: 259-264.
183. Rafanelli C, Bonomo M, Gostoli S: Is binge drinking in adolescence related to specific impairments in well-being? Psychother Psychosom 2016;85:366-367.
184. Sonino N, Fava GA: Rehabilitation in endocrine patients: a novel psychosomatic approach. Psychother Psychosom 2007; 76: 319-324.
185. Mojtabai R: Clinician-identified depression in community settings: concordance with structured-interview diagnoses. Psychother Psychosom 2013; 82: 161-169.
186. Ilyas S, Moncrieff J: Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. Br J Psychiatry 2012; 200: 393-398.
187. Cloos JM, Bocquet V, Rolland-Portal I, Koch P, Chouinard G: Hypnotics and triazolobenzodiazepines-best predictors of high-dose benzodiazepine use: results from the Luxembourg National Health Insurance Registry. Psychother Psychosom 2015; 84: 273-283.
188. Zito JM: High-dose benzodiazepine use among long-term users: when will we ever learn? Psychother Psychosom 2015; 84: 259-261.
189. Starcevic V, Brakoulias V, Viswasam K, Berle D: Inconsistent portrayal of medication dependence, withdrawal and discontinuation symptoms in treatment guidelines for anxiety disorders. Psychother Psychosom 2015; 84: 379-380.
190. Chouinard G, Chouinard VA: New classification of selective serotonin reuptake inhibitor withdrawal. Psychother Psychosom 2015; 84: 3-71.
191. Fava GA, Gatti A, Belaise C, Guidi J, Offidani E: Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation. Psychother Psychosom 2015; 84: 63-71.
192. Fava GA, Tomba E, Tossani E: Innovative trends in the design of clinical trials in psychopharmacology and psychotherapy. Progr Neuropsychopharmacol Biol Psychiatry 2013; 40: 306-311.
193. Fava GA, Cosci F, Tomba E: Iatrogenic comorbidity in mental health. Psychother Psychosom 2015; 84(suppl 1):22.
194. Ferrando SJ, Levenson JL, Owen JA (eds): Clinical Manual of Psychopharmacology in the Medically Ill. Washington, American Psychiatric Publishing, 2010.
195. Cosci F, Guidi J, Balon R, Fava GA: Clinical methodology matters in epidemiology: not all benzodiazepines are the same. Psychother Psychosom 2015; 84: 262-264.
196. Fava GA, Guidi J, Rafanelli C, Sonino N: The clinical inadequacy of evidence-based medicine and the need for a conceptual framework based on clinical judgment. Psychother Psychosom 2015; 84: 1-3.
197. Fava GA: Rational use of antidepressant drugs. Psychother Psychosom 2014; 83: 197-204.
198. Taylor D, Meader N, Bird V, Pilling S, Creed F, Goldberg D; Pharmacology subgroup of the National Institute for Health and Clinical Excellence Guideline Development Group for Depression in Chronic Physical Health Problems: Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy. Br J Psychiatry 2011; 198: 179-188.
199. Iovieno N, Tedeschini E, Ameral VE, Rigatelli M, Papakostas GI: Antidepressants for major depressive disorder in patients with co-morbid axis-III disorder. Int Clin Psychopharmacol 2011; 26: 69-74.
200. Jackson JL, de Zee K, Berbano E: Can treating depression improve disease outcomes? Ann Intern Med 2004; 140: 1054-1056.
201. Rackley S, Bostwick JM: Depression in medically ill patients. Psychiatr Clin North Am 2012; 35: 231-247.
202. Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA: The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom 2016; 85: 270-288.
203. Tinetti ME, Fried TR, Boyd CM: Designing health care for the most common chronic condition-multimorbidity. JAMA 2012; 307: 2493-2494.
204. Suls J, Green PA, Davidson KW: A biobehavioral framework to address the emerging challenge of multimorbidity. Psychosom Med 2016; 78: 281-289.
205. Linden M: Psychosomatic inpatient rehabilitation: the German model. Psychother Psychosom 2014; 83: 205-212.
206. Zipfel S, Herzog W, Kruse J, Henningsen P: Psychosomatic medicine in Germany: more timely than ever. Psychother Psychosom 2016; 85: 262-269.
207. Yoshiuci K: How can psychosomatic physicians contribute to behavioral medicine? Biopsychosoc Med 2016; 10: 8.
208. Nakao M, Takeuchi T, Fricchione G: Definition of psychosomatic medicine and the applicability of DSM-IV-TR to outpatients visiting a Japanese psychosomatic clinic. Psychother Psychosom 2014; 83: 120-121.
209. Yuan Y, Wu A, Jiang W: Psychosomatic medicine in China. Psychother Psychosom 2015; 84: 59-60.
210. Lipowski ZJ: Psychiatric consultation. Am J Psychiatry 1977; 134: 523-528.
211. Wood R, Wand AP: The effectiveness of consultation-liaison psychiatry in the general hospital setting. J Psychosom Res 2014; 76: 175-192.
212. Shaw RJ, Demaso DR (eds): Textbook of Pediatric Psychosomatic Medicine. Washington, American Psychiatric Publishing, 2010.
213. Wood R, Wand APF: The effectiveness of consultation-liaison psychiatry in the general hospital setting. J Psychosom Res 2014; 76: 175-192.
214. Sledge WH, Gueorguieva R, Desan P, Bozzo JE, Dorset J, Lee HB: Multidisciplinary proactive psychiatric consultation service: impact on length of stay for medical inpatients. Psychother Psychosom 2015; 84: 208-216.
215. Dantzer R: Somatization: a psychoneuroimmune perspective. Psychoneuroendocrinology 2005; 30: 947-952.
216. Thayer JF, Brosschot JF: Psychosomatics and psychopathology. Psychoneuroendocrinology 2005; 30: 1050-1058.
217. Schiffer RB, Klein RF, Sider RC: The Medical Evaluation of Psychiatric Patients. New York, Plenum, 1988.
218. Isaac ML, Larson EB: Medical conditions with neuropsychiatric manifestations. Med Clin North Am 2014; 98: 1193-1208.
219. Sonino N, Peruzzi P: A psychoneuroendocrinology service. Psychother Psychosom 2009; 78: 346-351.
220. The Remission Clinic Task Force: The Remission Clinic approach to halt the progression of kidney disease. J Nephrol 2011; 24: 274-281.
221. Fung-Kee-Fung M, Kennedy EB, Biagi J, Colgan T, D'Souza D, Elit LM, Hunter A, Irish J, McLeod R, Rosen B: The optimal organization of gynecologic oncology services: a systematic review. Curr Oncol 2015; 22:e282-e293.
222. Betteridge N, Boehncke WH, Bundy C, Gossec L, Gratacós J, Augustin M: Promoting patient-centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience. J Eur Acad Dermatol Venereol 2016; 30: 576-585.
223. Layard R, Clark DM: Why more psychological therapy would cost nothing. Front Psychol 2015; 6: 1713.
224. Hart JT: Clinical and economic consequences of patients as producers. J Public Health Med 1995; 17: 383-386.
225. Joosten EA, DeFuentes-Merillas L, de Weert GH, Sensky T, van der Staak CP, de Jong CA: Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom 2008; 77: 219-226.
226. Bodenheimer T, Lorig K, Holman H, Grumbach K: Patient self-management of chronic disease in primary care. JAMA 2002; 288: 2469-2475.
227. Kroenke K: Psychological medicine. BMJ 2002; 324: 1536-1537.
228. Ioannidis JPA: Evidence-based medicine has been hijacked: a report to David Sackett. J Clin Epidemiol 2016; 73: 82-86.
229. Horwitz RI, Cullen MR, Abell J, Christian JB: (De)personalized medicine. Science 2013; 339: 1155-1156.